Latest Period
Q2 2026
Security Snapshot
Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX) Institutional Ownership
CUSIP: 095633608
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
8
Shares (Excl. Options)
216,120
Price
$1.20
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- BJDX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 216,120
- Total 13F value
- $259,343
- Portfolio coverage rank
- 0%
- Share change
- +157,291
- Value change
- +$152,285
- Number of holders
- 8
- Shares outstanding
- 1,428,709
- SEC-reported price per share
- $1.06
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BJDX - Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 095633608.
- 8 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 6 to 8 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $108,244 to $259,343.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 8 institutions filings for Q2 2026.
Security key
095633608
Latest holder period
Q2 2026
13F holders
8
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
BJDX full holder history
Bluejay Diagnostics, Inc. SEC filings
Bluejay Diagnostics, Inc. company facts
Bluejay Diagnostics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 095633608:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
BJDX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | $199,819 | 142,728 | Armistice Capital, LLC | 30 Jun 2026 | |||
| Ayrton Capital LLC | 10% | $150,811 | 107,722 | Ayrton Capital LLC | 30 Jun 2026 |
As of 30 Jun 2026, 8 institutional investors reported holding 216,120 shares of Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX). This represents 15% of the company’s total 1,428,709 outstanding shares.
13F concentration
Top 11 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.2% | 131,000 | 0% | $157,200 | |
| HEIGHTS CAPITAL MANAGEMENT, INC | 2.5% | 35,400 | 0.01% | $42,480 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.9% | 27,130 | 0% | $32,556 | |
| BANK OF AMERICA CORP /DE/ | 0.72% | 10,337 | 0% | $12,404 | |
| VANGUARD FIDUCIARY TRUST CO | 0.72% | 10,225 | 0% | $12,270 | |
| Tower Research Capital LLC (TRC) | 0.13% | 1,907 | +10% | 0% | $2,288 |
| L1 Global Manager Pty Ltd | 0.01% | 120 | 0% | 0% | $144 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | -67% | 0% | $1 |
| SABBY MANAGEMENT, LLC | 0% | 0 | -100% | $0 | |
| UBS Group AG | 0% | 0 | -100% | $0 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3